Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| ClariMem® Health announces: Top Ivy League Researchers create Compound that Restores Crucial Brain Function in Older Adults in just 12 Weeks | ||
| By: PR Newswire Association LLC. - 28 Jun 2016 | Back to overview list |
|
BERKELEY, Calif., June 28, 2016 /PRNewswire/ -- ClariMem® Health, Inc., announced that its lead formula ClariMem® with L-TAMS was featured in the "Fighting Alzheimer's" section of USA Today on Friday 6/24/16. This mini-magazine in USA Today will be distributed to a 750,000 reader base, in addition to digital distribution among top partner organizations including the Alzheimer's Association, The National Institute of Aging and Maria Shriver. ClariMem® with L-TAMS is the only supplement shown to rejuvenate brain function as demonstrated by the only gold-plated human trial with results published in a peer-reviewed medical journal. L-TAMS, the ClariMem Health compound developed by neuroscientists at Stanford and MIT was found to increase synaptic density in the brain, reversing the scarce synaptic presence in older adults and others with impaired cognitive function. Published in the Journal of Alzheimer's Disease last year, a human trial on L-TAMS set it apart from its competitors, and is the key ingredient in ClariMem®. Moreover, this double-blind, placebo-controlled clinical trial illustrated with high statistical significance (p<0.01) that ClariMem® improved subjects' cognitive ability, as determined by a composite score of tests in four major cognitive domains: executive function, working memory, attention, and episodic memory. "We know that synaptic loss is a hallmark of the aging brain and the best-known predictor of cognitive impairment," said Zhong-Lin Lu, senior author of the aforementioned human trial and currently Director of the Center for Cognitive and Behavioral Brain Imaging at The Ohio State University. "ClariMem® successfully increases synaptic density and restores brain function, thereby increasing quality of life," Lu stated. To learn more about ClariMem® with L-TAMS and all the benefits it offers you, go to www.BuildaBetterBrain.com. About: ClariMem® Health, Inc., is a privately held biotechnology company focused on research and development of supplements that promote optimum brain health, restore memory, cognitive function, and sharper thinking.
SOURCE ClariMem Health, Inc. 
|
||
|
|
||
 | Back to overview list | |